Araim Pharmaceuticals, Inc.
1 registered trial on this site, 0 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.
Compounds covered
Registered trials
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With Sarcoidosis NCT02039687 | ARA-290 | Phase 2 | Completed | Araim Pharmaceuticals, Inc. | 64 | Jan 2015 | Apr 18, 2017 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.
